title: Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
abstract: Copy number variants (CNVs) are a recently recognized class of human germ line polymorphisms and are associated with a variety of human diseases, including cancer. Because of the strong genetic influence on prostate cancer, we sought to identify functionally active CNVs associated with susceptibility of this cancer type. We queried low-frequency biallelic CNVs from 1,903 men of Caucasian origin enrolled in the Tyrol Prostate Specific Antigen Screening Cohort and discovered two CNVs strongly associated with prostate cancer risk. The first risk locus (P = 7.7 × 10(-4), odds ratio = 2.78) maps to 15q21.3 and overlaps a noncoding enhancer element that contains multiple activator protein 1 (AP-1) transcription factor binding sites. Chromosome conformation capture (Hi-C) data suggested direct cis-interactions with distant genes. The second risk locus (P = 2.6 × 10(-3), odds ratio = 4.8) maps to the α-1,3-mannosyl-glycoprotein 4-β-N-acetylglucosaminyltransferase C (MGAT4C) gene on 12q21.31. In vitro cell-line assays found this gene to significantly modulate cell proliferation and migration in both benign and cancer prostate cells. Furthermore, MGAT4C was significantly overexpressed in metastatic versus localized prostate cancer. These two risk associations were replicated in an independent PSA-screened cohort of 800 men (15q21.3, combined P = 0.006; 12q21.31, combined P = 0.026). These findings establish noncoding and coding germ line CNVs as significant risk factors for prostate cancer susceptibility and implicate their role in disease development and progression.
authors.affiliation: Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA. demichelis@science.unitn.it
authors.forename: Francesca
authors.initials: F
authors.lastname: Demichelis
authors.forename: Sunita R
authors.initials: SR
authors.lastname: Setlur
authors.forename: Samprit
authors.initials: S
authors.lastname: Banerjee
authors.forename: Dimple
authors.initials: D
authors.lastname: Chakravarty
authors.forename: Jin Yun Helen
authors.initials: JY
authors.lastname: Chen
authors.forename: Chen X
authors.initials: CX
authors.lastname: Chen
authors.forename: Julie
authors.initials: J
authors.lastname: Huang
authors.forename: Himisha
authors.initials: H
authors.lastname: Beltran
authors.forename: Derek A
authors.initials: DA
authors.lastname: Oldridge
authors.forename: Naoki
authors.initials: N
authors.lastname: Kitabayashi
authors.forename: Birgit
authors.initials: B
authors.lastname: Stenzel
authors.forename: Georg
authors.initials: G
authors.lastname: Schaefer
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Horninger
authors.forename: Jasmin
authors.initials: J
authors.lastname: Bektic
authors.forename: Arul M
authors.initials: AM
authors.lastname: Chinnaiyan
authors.forename: Sagit
authors.initials: S
authors.lastname: Goldenberg
authors.forename: Javed
authors.initials: J
authors.lastname: Siddiqui
authors.forename: Meredith M
authors.initials: MM
authors.lastname: Regan
authors.forename: Michale
authors.initials: M
authors.lastname: Kearney
authors.forename: T David
authors.initials: TD
authors.lastname: Soong
authors.forename: David S
authors.initials: DS
authors.lastname: Rickman
authors.forename: Olivier
authors.initials: O
authors.lastname: Elemento
authors.forename: John T
authors.initials: JT
authors.lastname: Wei
authors.forename: Douglas S
authors.initials: DS
authors.lastname: Scherr
authors.forename: Martin A
authors.initials: MA
authors.lastname: Sanda
authors.forename: Georg
authors.initials: G
authors.lastname: Bartsch
authors.forename: Charles
authors.initials: C
authors.lastname: Lee
authors.forename: Helmut
authors.initials: H
authors.lastname: Klocker
authors.forename: Mark A
authors.initials: MA
authors.lastname: Rubin
mesh_terms: D016022:Case-Control Studies; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002881:Chromosomes, Human, Pair 12; D002884:Chromosomes, Human, Pair 15; D015331:Cohort Studies; D018628:Gene Dosage; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology